ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk ...
WASHINGTON, April 10 (Reuters) - U.S. health regulators are adding information to the labels on a popular class of birth control pills that includes Bayer AG's Yaz and Yasmin, to show they may raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback